Akorn Pharma
Data integrity scuppers Fresenius deal with Akorn
However Fresenius could be liable to pay $129m in termination fees
Fresenius says Akorn investigation could affect takeover
External ‘experts’ are investigating alleged breaches of data integrity requirements